Dermata Therapeutics, Inc. Contracts & Agreements

Form of Registration Rights Agreement (Filed With SEC on September 17, 2024)

Form of Securities Purchase Agreement (Filed With SEC on September 17, 2024)

Form of Placement Agent Warrant (Filed With SEC on September 17, 2024)

Form of Warrant (Filed With SEC on September 17, 2024)

Form of Pre-Funded Warrant (Filed With SEC on September 17, 2024)

ATM Agreement, dated June 7, 2024, by and between Dermata Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 7, 2024)

Form of Placement Agent Warrant (Filed With SEC on May 17, 2024)

Form of New Warrant (Filed With SEC on May 17, 2024)

Form of Inducement Letter (Filed With SEC on May 17, 2024)

Third Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (Filed With SEC on May 7, 2024)

Description of Securities (Filed With SEC on March 21, 2024)

Form of Inducement Letter (Filed With SEC on November 17, 2023)

Form of Placement Agent Warrant (Filed With SEC on November 17, 2023)

Form of New Warrant (Filed With SEC on November 17, 2023)

Second Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (Filed With SEC on August 3, 2023)

Form of Warrant (Filed With SEC on May 24, 2023)

Form of Pre-Funded Warrant (Filed With SEC on May 24, 2023)

Form of Placement Agent Warrant (Filed With SEC on May 24, 2023)

Form of Securities Purchase Agreement, dated May 23, 2023, by and between the Company and the Purchasers (Filed With SEC on May 24, 2023)

Form of Securities Purchase Agreement to be entered into in this Offering (Filed With SEC on March 16, 2023)

Form of Series A and Series B Common Warrant issued in this Offering (Filed With SEC on March 16, 2023)

Form of Pre-Funded Warrant issued in this Offering (Filed With SEC on March 13, 2023)

Engagement Letter, dated as of November 27, 2022, by and between Dermata Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 13, 2023)

Amendment No. 1 to the Engagement Letter, dated December 12, 2022, by and between Dermata Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 13, 2023)

Form of Common Warrant issued in this Offering (Filed With SEC on March 13, 2023)

Form of Placement Agent Warrant issued in this Offering (Filed With SEC on March 13, 2023)

Amendment No. 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Kyri K. Van Hoose (Filed With SEC on March 13, 2023)

Form of Securities Purchase Agreement to be entered into in this Offering (Filed With SEC on March 13, 2023)

Description of Securities (Filed With SEC on February 21, 2023)

Amendment No. 3 dated July 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher Nardo (Filed With SEC on August 15, 2022)

Form of Placement Agent Agreement dated April 20, 2022 between the Company and the Placement Agent (Filed With SEC on April 25, 2022)

Form of Registration Rights Agreement dated April 20, 2022 between the Company and the Purchaser (Filed With SEC on April 25, 2022)

Form of Securities Purchase Agreement dated April 20, 2022 between the Company and the Purchaser (Filed With SEC on April 25, 2022)

Form of Pre Funded Warrant (Filed With SEC on April 25, 2022)

Form of Common Stock Warrant (Filed With SEC on April 25, 2022)

Description of Securities (Filed With SEC on March 28, 2022)

Form of Pre-Funded Warrant sold in this offering (Filed With SEC on February 7, 2022)

Form of Warrant sold in this offering (Filed With SEC on February 7, 2022)

Amendment No. 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Kyri K. Van Hoose (Filed With SEC on February 4, 2022)

Amendment No. 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Maria Bedoya Toro Munera, Ph.D (Filed With SEC on February 4, 2022)

Amendment No. 2 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher J. Nardo (Filed With SEC on February 4, 2022)

PRE-FUNDED COMMON STOCK PURCHASE WARRANT DERMATA THERAPEUTICS, INC. (Filed With SEC on February 4, 2022)

Form of Pre-Funded Warrant (Filed With SEC on February 4, 2022)

Form of Warrant Agency Agreement between Dermata Therapeutics, Inc. and Direct Transfer, LLC (Filed With SEC on February 4, 2022)

Form of Underwriting Agreement (Filed With SEC on February 4, 2022)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on December 10, 2021)

Employment Agreement by and between Dermata Therapeutics, Inc. and Gerald T. Proehl dated December 6, 2021 (Filed With SEC on December 10, 2021)

Employment Agreement by and between Dermata Therapeutics, Inc. and Kyri Van Hoose dated December 6, 2021 (Filed With SEC on December 10, 2021)

Employment Agreement by and between Dermata Therapeutics, Inc. and Maria Bedoya Toro Munera dated December 6, 2021 (Filed With SEC on December 10, 2021)

Amendment dated December 6, 2021 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher J. Nardo dated August 17, 2021 (Filed With SEC on December 10, 2021)

Consulting Agreement, dated September 1, 2021, between the Company and Thomas Insley (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the... (Filed With SEC on November 15, 2021)

Consulting Agreement, dated September 1, 2021, between the Company and Thomas Insley (Filed With SEC on September 1, 2021)

Form of Common Stock Purchase Warrant (Filed With SEC on August 6, 2021)

Form of Underwriting Agreement (Filed With SEC on August 6, 2021)

Form of Underwriters Warrant (Filed With SEC on August 6, 2021)

Form of Warrant Agency Agreement between Dermata Therapeutics, Inc. and Direct Transfer, LLC (Filed With SEC on August 6, 2021)

Amendment to the License Amendment and Settlement Agreement between Dermata Therapeutics, Inc. and Villani, Inc., dated July 30, 2021 (Filed With SEC on August 6, 2021)

Amendment No. 1 to the Dermata Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on July 2, 2021)

License Amendment and Settlement Agreement between Dermata Therapeutics LLC and Villani, Inc. dated as of June 4, 2019 (Filed With SEC on July 2, 2021)

Amended and Restated Annex A to the License Agreement between Dermata Therapeutics LLC and Villani, Inc. dated as of March 31, 2017 (Filed With SEC on July 2, 2021)

License Agreement between Dermata Therapeutics LLC and Villani, Inc. dated as of March 31, 2017 (Filed With SEC on July 2, 2021)

Supply Agreement between Dermata Therapeutics LLC and Reka-Farm LLC, dated as of February 27, 2020 (Filed With SEC on July 2, 2021)

Form of Common Stock Purchase Warrant (Filed With SEC on June 10, 2021)

Specimen Certificate representing shares of common stock of Dermata Therapeutics, Inc (Filed With SEC on June 10, 2021)

Form of Indemnification Agreement to be entered into by Dermata Therapeutics, Inc. with its Officers and Directors (Filed With SEC on June 10, 2021)

Dermata Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 10, 2021)

Form of Nonqualified Stock Option Award under 2021 Equity Incentive Plan (Filed With SEC on June 10, 2021)

Form of Incentive Stock Option Award under 2021 Equity Incentive Plan (Filed With SEC on June 10, 2021)

Form of Employment Agreement by and between Dermata Therapeutics, Inc. and Gerald T. Proehl (Filed With SEC on June 10, 2021)

Form of Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher J. Nardo, M.P.H., Ph.D (Filed With SEC on June 10, 2021)

Form of Employment Agreement by and between Dermata Therapeutics, Inc. and Maria Bedoya Toro Munera, Ph.D., M.B.A (Filed With SEC on June 10, 2021)

Stockholders Agreement, dated March 24, 2021 (Filed With SEC on June 10, 2021)

Amendment No. 1 to the Stockholders Agreement, dated May 27, 2021 (Filed With SEC on June 10, 2021)

Category

Industry

Companies

Contracts

Dermata Therapeutics, Inc. Contracts & Agreements